News & Perspective

Apr 26, 2010

Apr 26, 2010

H1N1 LESSONS LEARNED Vaccine production foiled, confirmed experts' predictions

Second in a series marking the 1-year anniversary of novel H1N1 pandemic influenza. The first, on the virus itself, appeared Apr 23.

Nov 02, 2009

Nov 02, 2009

Studies reaffirm 2 vaccine doses in kids, show safety in pregnant women

(CIDRAP News) – Interim clinical trial findings announced today affirm that children younger than 10 need two pandemic H1N1 vaccine doses, and initial findings in pregnant women reveal no safety concerns and a need for only one dose.

Federal officials also detailed the role of an independent panel of experts to review vaccine safety data and released a report outlining the government's vaccine safety monitoring system.

Apr 29, 2009

Apr 29, 2009

Apr 28, 2009

Apr 28, 2009

Senate hearing raises pandemic readiness, funding issues

(CIDRAP News) –At an emergency hearing today of the Senate appropriations committee, Sen Tom Harkin, D-Iowa, said the Obama administration will ask for $1.5 billion to fight the swine influenza epidemic, as committee members sought to get a handle on the elements and cost estimates of the public health response.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Part 1: Flu research: a legacy of neglect

Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»